The same hypermethylation-based approach has been recently used to manipulate the levels of amyloid-beta (Aβ) precursor (APP) in cultured neurons from AD mice, resulting in decreased Aβ peptide levels, decreased Aβ42/40 ratio, and increased cell survival [66]. This evidence concerns the gene APP and Alzheimer disease.